EFFECT OF ORAL CONTRACEPTIVES ON BONE MINERAL DENSITY

Overview

Journal Acta Endocrinol (Buchar)

Specialty Endocrinology

Date 2023 Jan 26

PMID 36699167

Authors

C Ampatzis

S Zervoudis

G Iatrakis

G Mastorakos

Affiliations

Soon will be listed here.

Abstract

Contraceptives are widely used in our times and a lot of research has been conducted to clarify their impact on Bone Mineral Density. Combined Oral Contraceptives (COCs) may be detrimental to the BMD of adolescents. However, low-dose are more protective than ultra-low-dose COCs. When it comes to premenopause and perimenopause, COCs have no impact on BMD in women with good ovarian function and no estrogen deficiency. In women with impaired ovarian function, it seems that COCs have a positive influence on BMD. Progestin only-pills may not affect BMD, but further research is needed. Depot medroxyprogesterone acetate injection (DMPA) has a negative impact, especially in adolescents, which is duration related but evidence shows that BMD recovers after discontinuation. Levonorgestrel-releasing intrauterine system (LNG-IUS) has no impact on BMD.

Citing Articles

The Association Between Menstrual Cycle Phase, Menstrual Irregularities, Contraceptive Use and Musculoskeletal Injury Among Female Athletes: A Scoping Review.

MacMillan C, Olivier B, Viljoen C, van Rensburg D, Sewry N Sports Med. 2024; 54(10):2515-2530.

PMID: 39215933 PMC: 11467081. DOI: 10.1007/s40279-024-02074-5.

References

Khosla S, Oursler M, Monroe D . Estrogen and the skeleton. Trends Endocrinol Metab. 2012; 23(11):576-81. PMC: 3424385. DOI: 10.1016/j.tem.2012.03.008. View

Kaunitz A . Long-acting hormonal contraception: assessing impact on bone density, weight, and mood. Int J Fertil Womens Med. 1999; 44(2):110-7. View

Ziglar S, Hunter T . The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women. J Pharm Pract. 2012; 25(3):331-40. DOI: 10.1177/0897190012442066. View

Sordal T, Grob P, Verhoeven C . Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol. Acta Obstet Gynecol Scand. 2012; 91(11):1279-85. DOI: 10.1111/j.1600-0412.2012.01498.x. View

Tremollieres F . [Effect of hormonal contraception on bone mineral density]. Gynecol Obstet Fertil. 2005; 33(7-8):520-5. DOI: 10.1016/j.gyobfe.2005.05.016. View

Mansour D . The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception. Contraception. 2011; 85(3):224-34. DOI: 10.1016/j.contraception.2011.08.003. View

Aalberg K, Stavem K, Norheim F, Russell M, Chaibi A . Effect of oral and transdermal oestrogen therapy on bone mineral density in functional hypothalamic amenorrhoea: a systematic review and meta-analysis. BMJ Open Sport Exerc Med. 2021; 7(3):e001112. PMC: 8264872. DOI: 10.1136/bmjsem-2021-001112. View

Almstedt H, Cook M, Bramble L, Dabir D, LaBrie J . Oral contraceptive use, bone mineral density, and bone turnover markers over 12 months in college-aged females. J Bone Miner Metab. 2020; 38(4):544-554. PMC: 10317246. DOI: 10.1007/s00774-019-01081-1. View

Fine A, Busza A, Allen L, Kelly C, Wolfman W, Jacobson M . Comparing estrogen-based hormonal contraceptives and hormone therapy on bone mineral density in women with premature ovarian insufficiency: a systematic review. Menopause. 2022; 29(3):351-359. DOI: 10.1097/GME.0000000000001921. View

10.

Heller R, Cameron S, Johnstone A, Cochrane R, Glasier A . Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study. BMJ Sex Reprod Health. 2021; 48(1):69-70. DOI: 10.1136/bmjsrh-2021-201184. View

11.

Cromer B, Blair J, Mahan J, Zibners L, Naumovski Z . A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr. 1996; 129(5):671-6. DOI: 10.1016/s0022-3476(96)70148-8. View

12.

Sarfati J, de Vernejoul M . Impact of combined and progestogen-only contraceptives on bone mineral density. Joint Bone Spine. 2009; 76(2):134-8. DOI: 10.1016/j.jbspin.2008.09.014. View

13.

Nappi C, Di Spiezio Sardo A, Greco E, Tommaselli G, Giordano E, Guida M . Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol. 2004; 105(1):53-60. DOI: 10.1097/01.AOG.0000148344.26475.fc. View

14.

Taechakraichana N, Limpaphayom K, Ninlagarn T, Panyakhamlerd K, Chaikittisilpa S, Dusitsin N . A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women. Obstet Gynecol. 2000; 95(1):87-94. DOI: 10.1016/s0029-7844(99)00493-7. View

15.

Wong A, Tang L, Chin R . Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2010; 50(3):273-9. DOI: 10.1111/j.1479-828X.2010.01152.x. View

16.

Rome E, Ziegler J, Secic M, Bonny A, Stager M, Lazebnik R . Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive. J Pediatr Adolesc Gynecol. 2004; 17(6):373-7. DOI: 10.1016/j.jpag.2004.09.013. View

17.

Gemzell-Danielsson K, Inki P, Heikinheimo O . Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system. Acta Obstet Gynecol Scand. 2011; 90(11):1177-88. DOI: 10.1111/j.1600-0412.2011.01256.x. View

18.

. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

19.

Gambacciani M, Monteleone P, Ciaponi M, Sacco A, Genazzani A . Effects of oral contraceptives on bone mineral density. Treat Endocrinol. 2005; 3(3):191-6. DOI: 10.2165/00024677-200403030-00006. View

20.

Nguyen K, Chen X, Hughes T, Hofflich H, Woods G, McCowen K . SURPRISINGLY FEW WOMEN WITH SEVERE OSTEOPOROSIS BY BONE DENSITOMETRY UNDERGO WORKUP FOR SECONDARY CAUSES - A RETROSPECTIVE EVALUATION. Acta Endocrinol (Buchar). 2022; 17(4):537-542. PMC: 9206146. DOI: 10.4183/aeb.2021.537. View